Hematopoiesis Regulators

Hematopoiesis is the process of blood cell renewal in the body and occurs throughout adulthood. Growth factors enable the tight regulation of hematopoiesis, enabling new blood cells to differentiate, proliferate, and mature.

Red blood cells after hematopoiesis - By YAKOBCHUK VASYLYAKOBCHUK VASYL | Shutterstock

Blood cells have various lifespans and it is essential that they are replenished on a continual basis. Several cytokines enable the differentiation, proliferation, and maturation of eight types of blood cell. Some act upon a range of cell lineages, while others are highly specific.

Erythropoietin

Erythropoietin (EPO) regulates the process of erythropoiesis. This growth factor is a highly glycosylated polypeptide and is mainly produced in the kidneys. In a state of hypoxia (deficiency in oxygen supply to the tissues), the production of erythropoietin is stimulated by HIF‐1α and β (two types of hypoxia inducible factors).

EPO stimulates an increased number of myeloid progenitor cells to undergo erythropoiesis. The transcription factor GATA-2 initiates the erythroid maturation pathway. The earliest erythroid progenitors burst, forming unit-erythroid (BFUE) and erythroid colony forming unit (CFUE) both have receptors for erythropoietin on their surfaces.  When EPO binds to these receptors, proliferation, differentiation, and the production of haemoglobin is stimulated.

Thrombopoietin

The majority of thrombopoietin (TPO) is produced in the liver (95%) and is responsible for the regulation of thrombocyte production. TPO enables the fragmentation of megakaryocytes in the bone marrow.

Sialic acid is lost from thrombocytes as they come to the end of their lifespan (which is approximately 10 days). This leaves galactose residues exposed so that they can bind to Ashwell-Morell receptors in the liver. This triggers the production of TPO. TPO works to increase both the number and maturation of megakaryocytes by binding at c-MPL receptors.

Stem Cell Factor

Stem Cell Factor (SCF) also known as kit ligand which plays an integral role to regulate adult and embryonic hematopoiesis. SCF binds a tyrosine kinase receptor, c-kit, which results in the dimerization of the c-kit receptor and the subsequent activation of the tyrosine kinase domain.

Gene expression, cell proliferation and prevention of apoptosis are initiated by phosphorylation of tyrosine residues at the receptor site. This enables the binding of signalling proteins which allow these types of biochemical events to occur.

Interleukin 3 (IL-3), Interleukin 5 (IL-5) and Granulocyte Macrophage Colony Stimulating Factor (GM-CSF)

Derived from T-cells, IL-3 is required for the survival and proliferation of primitive hematopoietic progenitor cells. Much of its activity overlaps with IL-5 and GM-CSF, two other growth factors implicated in the hematopoietic process. Each of these ligands is made up of a cytokine alpha unit and the common beta subunit. This enables them to bind to the beta common receptor.

The differentiation of hematopoietic stem cells (HSCs) into myeloid progenitor cells is stimulated by IL-3. IL-3 in tandem with IL-7 enables the differentiation of HSC into lymphoid progenitor cells. This cytokine also works alongside GM-CSF to encourage the proliferation of cells in the myeloid lineage.

HSCs stimulated by GM-CSF produce both monocytes and granulocytes. GM-CSF is also known to prevent the migration of neutrophils.

IL-5 is produced by mast cells and T helper cells. Unlike IL-3 and GM-CSF, which act upon various cell lineages, IL-5 is primarily responsible for the maturation and release of eosinophils but it stimulates the differentiation of B-cells.

Further Reading

Last Updated: Nov 22, 2018

Maryam Mahdi

Written by

Maryam Mahdi

Maryam is a science writer with a passion for travel. She graduated in 2012 with a degree in Biomedical Sciences (B.Sc.) from the University of Manchester. Maryam previously worked in scientific education and has produced articles, videos, and presentations to highlight the association between dietary choices and cancer. She produces a range of articles for News-Medical, with a focus on microbiology and microscopy.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mahdi, Maryam. (2018, November 22). Hematopoiesis Regulators. News-Medical. Retrieved on November 21, 2024 from https://www.news-medical.net/life-sciences/Hematopoiesis-Regulators.aspx.

  • MLA

    Mahdi, Maryam. "Hematopoiesis Regulators". News-Medical. 21 November 2024. <https://www.news-medical.net/life-sciences/Hematopoiesis-Regulators.aspx>.

  • Chicago

    Mahdi, Maryam. "Hematopoiesis Regulators". News-Medical. https://www.news-medical.net/life-sciences/Hematopoiesis-Regulators.aspx. (accessed November 21, 2024).

  • Harvard

    Mahdi, Maryam. 2018. Hematopoiesis Regulators. News-Medical, viewed 21 November 2024, https://www.news-medical.net/life-sciences/Hematopoiesis-Regulators.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.